List view / Grid view
8 April 2015 | By Victoria White
Advaxis and Merck have initiated enrollment in the Phase 1/2 clinical trial evaluating the combination of ADXS-PSA and KEYTRUDA in patients with mCRPC...
8 April 2015 | By Victoria White
Lion Biotechnologies has announced that data from a study of metastatic cervical cancer patients treated with treated with HPV-TIL has been published...
8 April 2015 | By Victoria White
Capricor has announced that it has completed enrollment of the initial phase of its DYNAMIC clinical trial for the treatment of advanced heart failure...
8 April 2015 | By Victoria White
Gilead has submitted a NDA to the FDA for an investigational fixed-dose combination of F/TAF for the treatment of HIV-1 infection...
8 April 2015 | By Victoria White
The EU has approved Avastin in combination with chemotherapy for the treatment of persistent, recurrent or metastatic carcinoma of the cervix...
7 April 2015 | By Victoria White
The combined total revenues for the peer group of 35 mid-cap biotech companies increased from $24.8 billion in 2013 to $26.5 billion in 2014, representing a Compound Annual Growth Rate (CAGR) of 21.9%, according to research and consulting firm GlobalData.
7 April 2015 | By Victoria White
Ablynx has announced the start of a Phase IIb study to evaluate the efficacy and safety of ALX-0061 as a treatment for rheumatoid arthritis...
7 April 2015 | By Victoria White
Patients with pneumonia can initially be treated with most common antibiotics, according to research carried out by University Medical Centre Utrecht...
7 April 2015 | By Victoria White
Liver cancer treatment has the potential to undergo a major transformation over the next 10 years according to business intelligence provider GBI Research...
7 April 2015 | By Victoria White
Shire has announced a clear regulatory path for SHP465, an investigational medication being evaluated as a potential treatment for ADHD in adults...
7 April 2015 | By Victoria White
Breakthrough Therapy designation has been granted for rucaparib as treatment of advanced ovarian cancer in patients with BRCA-mutated tumours...
2 April 2015 | By Victoria White
Ocera has announced successful completion of a planned interim analysis of its OCR-002 STOP-HE study in patients with acute HE...
2 April 2015 | By Victoria White
OncoMed has entered into an agreement with Lilly. Demcizumab is being tested in combination with Alimta and carboplatin for the treatment of NSCLC...
2 April 2015 | By Victoria White
SAGE Therapeutics has announced details of its planned SAGE-547 global Phase 3 development programme for the treatment of patients with SRSE.
2 April 2015 | By Victoria White
pSivida has announced the completion of the targeted enrollment of 120 patients in its pivotal Phase III clinical trial of Medidur for posterior uveitis...
